Cogent Biosciences Statistics
Total Valuation
COGT has a market cap or net worth of $697.26 million. The enterprise value is $450.40 million.
Market Cap | 697.26M |
Enterprise Value | 450.40M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
Earnings Date | May 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
COGT has 103.91 million shares outstanding. The number of shares has increased by 35.61% in one year.
Shares Outstanding | 103.91M |
Shares Change (YoY) | +35.61% |
Shares Change (QoQ) | +0.75% |
Owned by Insiders (%) | 0.14% |
Owned by Institutions (%) | 100.15% |
Float | 80.04M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.70 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.09, with a Debt / Equity ratio of 0.07.
Current Ratio | 7.09 |
Quick Ratio | n/a |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -67.90% and return on invested capital (ROIC) is -75.23%.
Return on Equity (ROE) | -67.90% |
Return on Assets (ROA) | -58.10% |
Return on Capital (ROIC) | -75.23% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.17M |
Employee Count | 164 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.41% in the last 52 weeks. The beta is -0.08, so COGT's price volatility has been lower than the market average.
Beta (1Y) | -0.08 |
52-Week Price Change | -40.41% |
50-Day Moving Average | 6.92 |
200-Day Moving Average | 8.42 |
Relative Strength Index (RSI) | 51.58 |
Average Volume (30 Days) | 2,139,500 |
Short Selling Information
The latest short interest is 10.84 million, so 10.43% of the outstanding shares have been sold short.
Short Interest | 10.84M |
Short Previous Month | 9.63M |
Short % of Shares Out | 10.43% |
Short % of Float | 13.54% |
Short Ratio (days to cover) | 5.76 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -208.13M |
Pretax Income | -192.41M |
Net Income | -192.41M |
EBITDA | -188.82M |
EBIT | -192.41M |
Earnings Per Share (EPS) | -$2.42 |
Balance Sheet
The company has $265.71 million in cash and $18.85 million in debt, giving a net cash position of $246.86 million or $2.38 per share.
Cash & Cash Equivalents | 265.71M |
Total Debt | 18.85M |
Net Cash | 246.86M |
Net Cash Per Share | $2.38 |
Equity / Book Value | 257.80M |
Book Value Per Share | 2.48 |
Working Capital | 232.60M |
Cash Flow
In the last 12 months, operating cash flow was -$153.62 million and capital expenditures -$2.80 million, giving a free cash flow of -$156.42 million.
Operating Cash Flow | -153.62M |
Capital Expenditures | -2.80M |
Free Cash Flow | -156.42M |
FCF Per Share | -$1.96 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
COGT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -35.61% |
Shareholder Yield | -35.61% |
Earnings Yield | -27.60% |
FCF Yield | -22.43% |
Analyst Forecast
The average price target for COGT is $16.25, which is 142.18% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $16.25 |
Price Target Difference | 142.18% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 9, 2020. It was a reverse split with a ratio of 1:4.
Last Split Date | Nov 9, 2020 |
Split Type | Reverse |
Split Ratio | 1:4 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |